Children in Pancreatic Surgery: Indications, Procedures and Outcomes (ChiPS)

December 18, 2025 updated by: Richard Hunger, Medizinische Hochschule Brandenburg Theodor Fontane

Children in Pancreatic Surgery

Pediatric patients differ in a variety of properties from adult populations, but comprehensive multicenter or population-based data is missing for pancreatic surgery. This study aimed to evaluate indications, complications, and mortality in pediatric pancreatic surgery.

Study Overview

Detailed Description

This retrospective observational population-based cohort study analzes the German Diagnostic-Related Group database and included all children with pancreatic procedures between 2010 and 2023. The primary outcomes are mortality rates, complication rates, and sex differences related to surgical indication and pancreatic procedure. Descriptive epidemiological and multivariable regression analyses are performed to identify risk factors of mortality and occurrence of perioperative complications.

Study Type

Observational

Enrollment (Actual)

761

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All persons addmitted to a German hospital between 2010 and 2023. Population-based dataset.

Description

Inclusion Criteria:

  • stationary hospital admission
  • pancreatic surgical procedure

Exclusion Criteria:

  • unknown sex or age
  • admission for pancreas tranplantation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic pancreatitis
Procedure codes: 5-524.1; 5-524.2; 5-524.3
Procedure codes: 5-525.*
Procedure code: 5-524.0
Procedure codes: 5-527.*
Procedure codes: 5-520.*
Procedure codes: 5-523.*
Procedure codes: 5-521.*
Procedure codes: 5-522.*
Procedure codes: 5-524.0*; 5-524-x; 5-524.y
Pancreatic tumor
Procedure codes: 5-524.1; 5-524.2; 5-524.3
Procedure codes: 5-525.*
Procedure code: 5-524.0
Procedure codes: 5-527.*
Procedure codes: 5-520.*
Procedure codes: 5-523.*
Procedure codes: 5-521.*
Procedure codes: 5-522.*
Procedure codes: 5-524.0*; 5-524-x; 5-524.y
Trauma
Procedure codes: 5-524.1; 5-524.2; 5-524.3
Procedure codes: 5-525.*
Procedure code: 5-524.0
Procedure codes: 5-527.*
Procedure codes: 5-520.*
Procedure codes: 5-523.*
Procedure codes: 5-521.*
Procedure codes: 5-522.*
Procedure codes: 5-524.0*; 5-524-x; 5-524.y
Extra-pancreatic neoplasm
Procedure codes: 5-524.1; 5-524.2; 5-524.3
Procedure codes: 5-525.*
Procedure code: 5-524.0
Procedure codes: 5-527.*
Procedure codes: 5-520.*
Procedure codes: 5-523.*
Procedure codes: 5-521.*
Procedure codes: 5-522.*
Procedure codes: 5-524.0*; 5-524-x; 5-524.y
Other diseases
Procedure codes: 5-524.1; 5-524.2; 5-524.3
Procedure codes: 5-525.*
Procedure code: 5-524.0
Procedure codes: 5-527.*
Procedure codes: 5-520.*
Procedure codes: 5-523.*
Procedure codes: 5-521.*
Procedure codes: 5-522.*
Procedure codes: 5-524.0*; 5-524-x; 5-524.y

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mortality rate
Time Frame: 30 days
Perioperative death
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complication rates
Time Frame: 30 days
Perioperative surgical-related complication
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2010

Primary Completion (Actual)

December 31, 2023

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

December 5, 2025

First Submitted That Met QC Criteria

December 5, 2025

First Posted (Estimated)

December 18, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 18, 2025

Last Verified

October 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data is held and provided by the Federal Statistical Office of Germany and the statistical offices of the federal states. Due to data privacy regulations, data sharing is strictly prohibited by German law. Furthermore, the data was evaluated exclusively within the framework of controlled remote data analysis. This meant that we never had direct access to the raw data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Children

Clinical Trials on Pancreatoduodenectomy

Subscribe